Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04750655
Other study ID # IRB#20-30037
Secondary ID
Status Recruiting
Phase Phase 4
First received
Last updated
Start date March 1, 2021
Est. completion date December 2023

Study information

Verified date August 2022
Source University of California, San Francisco
Contact Sean Yonamine, BA, BS
Phone 909-268-7390
Email sean.yonamine@ucsf.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this study, the investigators seek to determine the effect of antibiotic use post-surgery on antimicrobial resistance. The investigators will be studying adults (aged 18 or older) who will undergo eye surgery at University of California, San Francisco (UCSF). We seek to gain a better understanding of how antibiotic use during the perioperative period influences local and systemic antibiotic resistance at the individual level.


Description:

Antibiotic use has saved millions of lives globally. However, this comes at the cost of selecting for antibiotic-resistant organisms at the individual and the community level. It is estimated that every year, approximately 700,000 deaths are associated with drug resistance globally. This places a significant burden on the public health system and the judicious use of antibiotics is more important than ever before. The proposed masked, randomized controlled trial evaluates the effects of topical antibiotic use on the selection of antibiotic resistance determinants at the local and systemic levels. The results will provide guidance for antibiotic usage in ophthalmology and may have the potential to inform public health policies.


Recruitment information / eligibility

Status Recruiting
Enrollment 108
Est. completion date December 2023
Est. primary completion date December 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria: 1. Over 18 years of age 2. Undergoing cataract surgeries that would benefit from intracameral antibiotics 3. Able to provide swabs 4. Able to provide consent 5. Surgery of the second eye occurs at least 8 weeks after surgery of the first eye Exclusion Criteria: 1. Same-day bilateral cataract surgeries 2. On immunosuppression medication such as Prednisone, Methotrexate, Cellcept, or anti-TNF inhibitors within past 3 months 3. On systemic antibiotic within past 3 months 4. On topical antibiotics within past 8 weeks 5. Allergies to fluoroquinolone 6. Patients needing glaucoma drainage device or trabeculectomy 7. Inability to consent

Study Design


Intervention

Drug:
Moxifloxacin (Topical)
We are using moxifloxacin as indicated and as intended for use as an antibiotic during surgery. Frequency of postoperative antibiotics dependent on group randomization.

Locations

Country Name City State
United States University of California, San Francisco San Francisco California

Sponsors (1)

Lead Sponsor Collaborator
University of California, San Francisco

Country where clinical trial is conducted

United States, 

References & Publications (1)

Gaynor BD, Chidambaram JD, Cevallos V, Miao Y, Miller K, Jha HC, Bhatta RC, Chaudhary JS, Osaki Holm S, Whitcher JP, Holbrook KA, Fry AM, Lietman TM. Topical ocular antibiotics induce bacterial resistance at extraocular sites. Br J Ophthalmol. 2005 Sep;89(9):1097-9. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Antimicrobial Resistance (AMR) of Conjunctiva at 1 week Normalized read counts (reads per million reads or rM) for fluoroquinolone resistance determinants from DNA deep sequencing for the conjunctival swabs at 1 week. 1 Week
Primary Antimicrobial Resistance (AMR) of Nasopharynx at 1 week Normalized read counts (reads per million reads or rM) for fluoroquinolone resistance determinants from DNA deep sequencing for the nasopharyngeal swabs at 1 week. 1 week
Primary Antimicrobial Resistance (AMR) of Oral at 1 week Normalized read counts (reads per million reads or rM) for fluoroquinolone resistance determinants for the buccal swabs at 1 week. 1 week
Primary Antimicrobial Resistance (AMR) of Gut at 1 Week Normalized reads counts (reads per million reads or rM) for fluoroquinolone resistance determinants for the rectal swabs at 1 week. 1 week
Secondary Ocular Surface Microbiome with Shannon's diversity index at 1 week Shannon's diversity index (H) will be measured to calculate species richness of ocular surface microbiome at 1 week. Shannon's diversity index (H) is calculated through the following formula, H = -sum(pi*log(b)*pi), where pi is the proportional abundance of species and b is the base of the logarithm. 1 week
Secondary Ocular Surface Microbiome with Simpson's diversity index at 1 week Simpson's diversity index (D) will be measured to calculate species richness of ocular surface microbiome at 1 week. Simpson's diversity index (D) is calculated through the following formula, D = sum(pi^2), where pi is the proportional abundance of species. 1 week
Secondary Ocular Surface Microbiome with Shannon's diversity index at 1 month Shannon's diversity index (H) will be measured to calculate species richness of ocular surface microbiome at 1 month. Shannon's diversity index (H) is calculated through the following formula, H = -sum(pi*log(b)*pi), where pi is the proportional abundance of species and b is the base of the logarithm. 1 month
Secondary Ocular Surface Microbiome with Simpson's diversity index at 1 month Simpson's diversity index (D) will be measured to calculate species richness of ocular surface microbiome at 1 month. Simpson's diversity index (D) is calculated through the following formula, D = sum(pi^2), where pi is the proportional abundance of species. 1 month
Secondary Nasopharyngeal Microbiome with Shannon's diversity index at 1 week Shannon's diversity index (H) will be measured to calculate species richness of nasopharyngeal microbiome at 1 week. Shannon's diversity index (H) is calculated through the following formula, H = -sum(pi*log(b)*pi), where pi is the proportional abundance of species and b is the base of the logarithm. 1 week
Secondary Nasopharyngeal Microbiome with Simpson's diversity index at 1 week Simpson's diversity index (D) will be measured to calculate species richness of nasopharyngeal microbiome at 1 week. Simpson's diversity index (D) is calculated through the following formula, D = sum(pi^2), where pi is the proportional abundance of species. 1 week
Secondary Nasopharyngeal Microbiome with Shannon's diversity index at 1 month Shannon's diversity index (H) will be measured to calculate species richness of nasopharyngeal microbiome at 1 month. Shannon's diversity index (H) is calculated through the following formula, H = -sum(pi*log(b)*pi), where pi is the proportional abundance of species and b is the base of the logarithm. 1 month
Secondary Nasopharyngeal Microbiome with Simpson's diversity index at 1 month Simpson's diversity index (D) will be measured to calculate species richness of nasopharyngeal microbiome at 1 month. Simpson's diversity index (D) is calculated through the following formula, D = sum(pi^2), where pi is the proportional abundance of species. 1 month
Secondary Gut Microbiome with Shannon's diversity index at 1 week Shannon's diversity index (H) will be measured to calculate species richness of gut microbiome at 1 week. Shannon's diversity index (H) is calculated through the following formula, H = -sum(pi*log(b)*pi), where pi is the proportional abundance of species and b is the base of the logarithm. 1 week
Secondary Gut Microbiome with Simpson's diversity index at 1 week Simpson's diversity index (D) will be measured to calculate species richness of gut microbiome at 1 week. Simpson's diversity index (D) is calculated through the following formula, D = sum(pi^2), where pi is the proportional abundance of species. 1 week
Secondary Oral Microbiome with Shannon's diversity index at 1 Week Shannon's diversity index (H) will be measured to calculate species richness of oral microbiome at 1 week. Shannon's diversity index (H) is calculated through the following formula, H = -sum(pi*log(b)*pi), where pi is the proportional abundance of species and b is the base of the logarithm. 1 week
Secondary Oral Microbiome with Simpson's diversity index at 1 Week Simpson's diversity index (D) will be measured to calculate species richness of oral microbiome at 1 week. Simpson's diversity index (D) is calculated through the following formula, D = sum(pi^2), where pi is the proportional abundance of species. 1 week
Secondary Oral Microbiome with Shannon's diversity index at 1 Month Shannon's diversity index (H) will be measured to calculate species richness of oral microbiome at 1 month. Shannon's diversity index (H) is calculated through the following formula, H = -sum(pi*log(b)*pi), where pi is the proportional abundance of species and b is the base of the logarithm. 1 month
Secondary Oral Microbiome with Simpson's diversity index at 1 Month Simpson's diversity index (D) will be measured to calculate species richness of oral microbiome at 1 month. Simpson's diversity index (D) is calculated through the following formula, D = sum(pi^2), where pi is the proportional abundance of species. 1 month
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03174236 - First Line Antimicrobials in Children With Complicated Severe Acute Malnutrition Phase 3
Recruiting NCT02566928 - Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence Phase 4
Completed NCT05195866 - CRP for Respiratory Diagnosis in Kyrgyz Pediatric Practice N/A
Recruiting NCT04544072 - Analysis of the Quality and Quantity of Antibiotic Prescriptions for Bacterial Respiratory Tract Superinfection in Patients Hospitalized in COVID-19 Wards
Completed NCT04028830 - Impact on Antibiotic Prescriptions of a Bundle Intervention Conducted by Medical Representatives in General Practitioner Facilities, Based on Operational Demonstration of an Internet Decision Support Tool: Antibioclic N/A
Completed NCT03790254 - D Mannose for Prevention and Treatment of RUTIs
Recruiting NCT02367339 - Assessment of the Prevalence of Extended-Spectrum Betalactamase Producing Enterobacteriaceae Among ICU Staff N/A
Not yet recruiting NCT05606627 - Correlation Between Antibiotic Resistance and Incidence of Sepsis in Community Acquired Pneumonia
Completed NCT02591901 - Preventing UTIs in Chronic Neurogenic Bladder Dysfunction (Mix Methods) Phase 2
Not yet recruiting NCT06371560 - Antibiotics, Antibiotic Resistance, and Prescribing Practices Among Periodontists: Cross Sectional KAP Study